The Antimicrobial Resistance Characteristics of Imipenem-Non-Susceptible, Imipenemase-6-Producing <i>Escherichia coli</i>

Imipenemase-6 (IMP-6) type carbapenemase-producing <i>Enterobacteriaceae</i> is regarded as dangerous due to its unique lack of antimicrobial susceptibility. It is resistant to meropenem (MEPM) but susceptible to imipenem (IPM). In addition to carbapenemase, outer membrane porins and eff...

Full description

Bibliographic Details
Main Authors: Reo Onishi, Katsumi Shigemura, Kayo Osawa, Young-Min Yang, Koki Maeda, Shiuh-Bin Fang, Shian-Ying Sung, Kenichiro Onuma, Atsushi Uda, Takayuki Miyara, Masato Fujisawa
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:Antibiotics
Subjects:
Online Access:https://www.mdpi.com/2079-6382/11/1/32
_version_ 1797496345612779520
author Reo Onishi
Katsumi Shigemura
Kayo Osawa
Young-Min Yang
Koki Maeda
Shiuh-Bin Fang
Shian-Ying Sung
Kenichiro Onuma
Atsushi Uda
Takayuki Miyara
Masato Fujisawa
author_facet Reo Onishi
Katsumi Shigemura
Kayo Osawa
Young-Min Yang
Koki Maeda
Shiuh-Bin Fang
Shian-Ying Sung
Kenichiro Onuma
Atsushi Uda
Takayuki Miyara
Masato Fujisawa
author_sort Reo Onishi
collection DOAJ
description Imipenemase-6 (IMP-6) type carbapenemase-producing <i>Enterobacteriaceae</i> is regarded as dangerous due to its unique lack of antimicrobial susceptibility. It is resistant to meropenem (MEPM) but susceptible to imipenem (IPM). In addition to carbapenemase, outer membrane porins and efflux pumps also play roles in carbapenem resistance by reducing the antimicrobial concentration inside cells. Extended-spectrum β-lactamase (ESBL) is transmitted with IMP-6 by the plasmid and broadens the spectrum of antimicrobial resistance. We collected 42 strains of IMP-6-producing <i>Escherichia coli</i> and conducted a molecular analysis of carbapenemase, ESBL, porin, efflux, and epidemiological characteristics using plasmid replicon typing. Among the 42 isolates, 21 strains were susceptible to IPM (50.0%) and 1 (2.4%) to MEPM. Seventeen strains (40.5%) co-produced CTX-M-2 type ESBL. We found that the relative expression of <i>ompC</i> and <i>ompF</i> significantly correlated with the MIC of IPM (<i>p</i> = 0.01 and <i>p</i> = 0.03, respectively). Sixty-eight% of CTX-M-2-non-producing strains had IncI1, which was significantly different from CTX-M-2-producing strains (<i>p</i> < 0.001). In conclusion, 50.0% of our IMP-6-producing strains were non-susceptible to IPM, which is different from the typical pattern and can be attributed to decreased porin expression. Further studies investigating other types of carbapenemase are warranted.
first_indexed 2024-03-10T03:02:21Z
format Article
id doaj.art-070b6ae7431b4294a0488af26d13777b
institution Directory Open Access Journal
issn 2079-6382
language English
last_indexed 2024-03-10T03:02:21Z
publishDate 2021-12-01
publisher MDPI AG
record_format Article
series Antibiotics
spelling doaj.art-070b6ae7431b4294a0488af26d13777b2023-11-23T12:42:58ZengMDPI AGAntibiotics2079-63822021-12-011113210.3390/antibiotics11010032The Antimicrobial Resistance Characteristics of Imipenem-Non-Susceptible, Imipenemase-6-Producing <i>Escherichia coli</i>Reo Onishi0Katsumi Shigemura1Kayo Osawa2Young-Min Yang3Koki Maeda4Shiuh-Bin Fang5Shian-Ying Sung6Kenichiro Onuma7Atsushi Uda8Takayuki Miyara9Masato Fujisawa10Department of Public Health, Division of Infectious Diseases, Kobe University Graduate School of Health Sciences, 7-10-2 Tomogaoka Suma-ku, Kobe 654-0142, JapanDepartment of Public Health, Division of Infectious Diseases, Kobe University Graduate School of Health Sciences, 7-10-2 Tomogaoka Suma-ku, Kobe 654-0142, JapanDepartment of Medical Technology, Kobe Tokiwa University, 2-6-2 Otani-cho, Nagata-ku, Kobe 653-0838, JapanDivision of Urology, Kobe University Graduate School of Medicine, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe 650-0017, JapanDivision of Urology, Kobe University Graduate School of Medicine, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe 650-0017, JapanDepartment of Pediatrics, Division of Pediatric Gastroenterology and Hepatology, Shuang Ho Hospital, Taipei Medical University, 291 Jhong Jheng Road, Jhong Ho District, New Taipei City 23561, TaiwanInternational Ph.D. Program for Translational Science, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, TaiwanDepartment of Infection Control and Prevention, Kobe University Hospital, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe 650-0017, JapanDepartment of Infection Control and Prevention, Kobe University Hospital, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe 650-0017, JapanDepartment of Infection Control and Prevention, Kobe University Hospital, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe 650-0017, JapanDivision of Urology, Kobe University Graduate School of Medicine, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe 650-0017, JapanImipenemase-6 (IMP-6) type carbapenemase-producing <i>Enterobacteriaceae</i> is regarded as dangerous due to its unique lack of antimicrobial susceptibility. It is resistant to meropenem (MEPM) but susceptible to imipenem (IPM). In addition to carbapenemase, outer membrane porins and efflux pumps also play roles in carbapenem resistance by reducing the antimicrobial concentration inside cells. Extended-spectrum β-lactamase (ESBL) is transmitted with IMP-6 by the plasmid and broadens the spectrum of antimicrobial resistance. We collected 42 strains of IMP-6-producing <i>Escherichia coli</i> and conducted a molecular analysis of carbapenemase, ESBL, porin, efflux, and epidemiological characteristics using plasmid replicon typing. Among the 42 isolates, 21 strains were susceptible to IPM (50.0%) and 1 (2.4%) to MEPM. Seventeen strains (40.5%) co-produced CTX-M-2 type ESBL. We found that the relative expression of <i>ompC</i> and <i>ompF</i> significantly correlated with the MIC of IPM (<i>p</i> = 0.01 and <i>p</i> = 0.03, respectively). Sixty-eight% of CTX-M-2-non-producing strains had IncI1, which was significantly different from CTX-M-2-producing strains (<i>p</i> < 0.001). In conclusion, 50.0% of our IMP-6-producing strains were non-susceptible to IPM, which is different from the typical pattern and can be attributed to decreased porin expression. Further studies investigating other types of carbapenemase are warranted.https://www.mdpi.com/2079-6382/11/1/32IMP-6carbapenemaseporinefflux pumpplasmid
spellingShingle Reo Onishi
Katsumi Shigemura
Kayo Osawa
Young-Min Yang
Koki Maeda
Shiuh-Bin Fang
Shian-Ying Sung
Kenichiro Onuma
Atsushi Uda
Takayuki Miyara
Masato Fujisawa
The Antimicrobial Resistance Characteristics of Imipenem-Non-Susceptible, Imipenemase-6-Producing <i>Escherichia coli</i>
Antibiotics
IMP-6
carbapenemase
porin
efflux pump
plasmid
title The Antimicrobial Resistance Characteristics of Imipenem-Non-Susceptible, Imipenemase-6-Producing <i>Escherichia coli</i>
title_full The Antimicrobial Resistance Characteristics of Imipenem-Non-Susceptible, Imipenemase-6-Producing <i>Escherichia coli</i>
title_fullStr The Antimicrobial Resistance Characteristics of Imipenem-Non-Susceptible, Imipenemase-6-Producing <i>Escherichia coli</i>
title_full_unstemmed The Antimicrobial Resistance Characteristics of Imipenem-Non-Susceptible, Imipenemase-6-Producing <i>Escherichia coli</i>
title_short The Antimicrobial Resistance Characteristics of Imipenem-Non-Susceptible, Imipenemase-6-Producing <i>Escherichia coli</i>
title_sort antimicrobial resistance characteristics of imipenem non susceptible imipenemase 6 producing i escherichia coli i
topic IMP-6
carbapenemase
porin
efflux pump
plasmid
url https://www.mdpi.com/2079-6382/11/1/32
work_keys_str_mv AT reoonishi theantimicrobialresistancecharacteristicsofimipenemnonsusceptibleimipenemase6producingiescherichiacolii
AT katsumishigemura theantimicrobialresistancecharacteristicsofimipenemnonsusceptibleimipenemase6producingiescherichiacolii
AT kayoosawa theantimicrobialresistancecharacteristicsofimipenemnonsusceptibleimipenemase6producingiescherichiacolii
AT youngminyang theantimicrobialresistancecharacteristicsofimipenemnonsusceptibleimipenemase6producingiescherichiacolii
AT kokimaeda theantimicrobialresistancecharacteristicsofimipenemnonsusceptibleimipenemase6producingiescherichiacolii
AT shiuhbinfang theantimicrobialresistancecharacteristicsofimipenemnonsusceptibleimipenemase6producingiescherichiacolii
AT shianyingsung theantimicrobialresistancecharacteristicsofimipenemnonsusceptibleimipenemase6producingiescherichiacolii
AT kenichiroonuma theantimicrobialresistancecharacteristicsofimipenemnonsusceptibleimipenemase6producingiescherichiacolii
AT atsushiuda theantimicrobialresistancecharacteristicsofimipenemnonsusceptibleimipenemase6producingiescherichiacolii
AT takayukimiyara theantimicrobialresistancecharacteristicsofimipenemnonsusceptibleimipenemase6producingiescherichiacolii
AT masatofujisawa theantimicrobialresistancecharacteristicsofimipenemnonsusceptibleimipenemase6producingiescherichiacolii
AT reoonishi antimicrobialresistancecharacteristicsofimipenemnonsusceptibleimipenemase6producingiescherichiacolii
AT katsumishigemura antimicrobialresistancecharacteristicsofimipenemnonsusceptibleimipenemase6producingiescherichiacolii
AT kayoosawa antimicrobialresistancecharacteristicsofimipenemnonsusceptibleimipenemase6producingiescherichiacolii
AT youngminyang antimicrobialresistancecharacteristicsofimipenemnonsusceptibleimipenemase6producingiescherichiacolii
AT kokimaeda antimicrobialresistancecharacteristicsofimipenemnonsusceptibleimipenemase6producingiescherichiacolii
AT shiuhbinfang antimicrobialresistancecharacteristicsofimipenemnonsusceptibleimipenemase6producingiescherichiacolii
AT shianyingsung antimicrobialresistancecharacteristicsofimipenemnonsusceptibleimipenemase6producingiescherichiacolii
AT kenichiroonuma antimicrobialresistancecharacteristicsofimipenemnonsusceptibleimipenemase6producingiescherichiacolii
AT atsushiuda antimicrobialresistancecharacteristicsofimipenemnonsusceptibleimipenemase6producingiescherichiacolii
AT takayukimiyara antimicrobialresistancecharacteristicsofimipenemnonsusceptibleimipenemase6producingiescherichiacolii
AT masatofujisawa antimicrobialresistancecharacteristicsofimipenemnonsusceptibleimipenemase6producingiescherichiacolii